Arkema Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Arkema hat ein Gesamteigenkapital von €7.5B und eine Gesamtverschuldung von €4.4B, wodurch sich der Verschuldungsgrad auf 59.1% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen €14.7B bzw. €7.2B. Arkema Das EBIT des Unternehmens beträgt €686.0M, so dass der Zinsdeckungsgrad 20.2 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von €2.0B.

Wichtige Informationen

59.1%

Verhältnis von Schulden zu Eigenkapital

€4.41b

Verschuldung

Zinsdeckungsgrad	20.2x
Bargeld	€2.00b
Eigenkapital	€7.45b
Gesamtverbindlichkeiten	€7.20b
Gesamtvermögen	€14.66b

Jüngste Berichte zur Finanzlage

Recent updates

Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 09

Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality

Aug 08

Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 05

We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt

Jul 16

Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year

May 13

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Apr 25

Is Arkema (EPA:AKE) A Risky Investment?

Mar 29

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Mar 08

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 02

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Dec 30

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Dec 15

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Nov 29

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Sep 07

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Aug 20

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Aug 02

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

May 28

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

May 13

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

May 09

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Apr 24

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Apr 05

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Feb 26

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Feb 14

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Jan 30

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Jan 14

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Nov 02

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Oct 11

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Jul 19

What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?

Jul 04

If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late

Jun 03

Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's

May 10

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Apr 25

Is There An Opportunity With Arkema S.A.'s (EPA:AKE) 47% Undervaluation?

Apr 24

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.00

Apr 10

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00

Mar 27

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: AKEDie kurzfristigen Aktiva des Unternehmens (€5.1B) übersteigen seine kurzfristigen Passiva (€2.4B).

Langfristige Verbindlichkeiten: AKEDie kurzfristigen Vermögenswerte des Unternehmens (€5.1B) übersteigen seine langfristigen Verbindlichkeiten (€4.8B).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: AKEDie Nettoverschuldung im Verhältnis zum Eigenkapital (32.4%) wird als zufriedenstellend angesehen.

Schulden abbauen: AKEDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 46.6% auf 59.1% gestiegen.

Schuldendeckung: AKEDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (26.7%).

Zinsdeckung: AKEDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (20.2x Coverage) gut gedeckt.

Arkema Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt

Is Arkema (EPA:AKE) A Risky Investment?

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Recent updates

Arkema S.A. to Report First Half, 2025 Results on Jul 31, 2025

Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Third quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Arkema S.A. to Report Q1, 2025 Results on May 07, 2025

Arkema Launches Ethyl Acrylate Based Entirely on Bioethanol

Arkema S.A. Announces Management Changes

Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality

Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Arkema S.A. to Report Fiscal Year 2024 Results on Feb 27, 2025

We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt

Consensus EPS estimates fall by 11%

Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of €3.50 per share

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Arkema S.A. (ENXTPA:AKE) agreed to acquire The Dow Chemical Company from Dow Inc. (NYSE:DOW) for an enterprise value of $150 million.

Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50

Is Arkema (EPA:AKE) A Risky Investment?

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50

Dividend increased to €3.50

Consensus EPS estimates fall by 20%

Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Full year 2023 earnings: EPS misses analyst expectations

Arkema S.A. to Report Q2, 2024 Results on Aug 01, 2024

Arkema S.A. (ENXTPA:AKE) acquired an unknown minority stake in Tiamat.

Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet

An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued

Arkema S.A. (ENXTPA:AKE) acquired Arc Bulding Products.

Arkema S.A. (ENXTPA:AKE) completed the acquisition of 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity.

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Arkema S.A. to Report Q1, 2024 Results on May 07, 2024

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Arkema S.A., Annual General Meeting, May 15, 2024

Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?

Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?

Second quarter 2023 earnings: EPS in line with expectations, revenues disappoint

Now 21% undervalued

Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million.

Arkema S.A. (ENXTPA:AKE) agreed to acquire a 54% stake in PI Advanced Materials Co., Ltd. (KOSE:A178920) from Glenwood Private Equity for approximately €730 million.

Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates increase by 11%

Arkema S.A. agreed to acquire Polytec PT GmbH Polymere Technologien.

Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40

Arkema S.A. Appoints Florence Lambert and Séverin Cabannes as Director

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?

Upcoming dividend of €3.40 per share at 3.9% yield

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Why Arkema S.A. (EPA:AKE) Could Be Worth Watching

Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 11%, revenue upgraded

Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40

Full year 2022 earnings: EPS misses analyst expectations

Arkema S.A. Announces Executive Changes

Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet

Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?

Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?

Prayon S.A. completed the acquisition of Febex S.A from Arkema S.A. (ENXTPA:AKE).

Arkema S.A. to Report Q1, 2023 Results on May 05, 2023

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly

Prayon S.A. entered into an agreement to acquire Febex S.A from Arkema S.A. (ENXTPA:AKE).

Price target decreased to €104

Price target decreased to €106

At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?

Arkema S.A. (ENXTPA:AKE) acquired Polimeros Especiales, S.A. De C.V.

Arkema S.A. to Report Fiscal Year 2022 Results on Feb 23, 2023